{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:10:09Z","timestamp":1782951009402,"version":"3.54.5"},"reference-count":60,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T00:00:00Z","timestamp":1605225600000},"content-version":"vor","delay-in-days":226,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RO1 DK074932"],"award-info":[{"award-number":["RO1 DK074932"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1074\/jbc.ra119.012361","type":"journal-article","created":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T01:45:22Z","timestamp":1582249522000},"page":"4631-4646","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Hepatic HAX-1 inactivation prevents metabolic diseases by enhancing mitochondrial activity and bile salt export"],"prefix":"10.1016","volume":"295","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3702-7138","authenticated-orcid":false,"given":"Fawzi","family":"Alogaili","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sivaprakasam","family":"Chinnarasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Jaeschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelia G.","family":"Kranias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7333-2151","authenticated-orcid":false,"given":"David Y.","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.RA119.012361_bib1","doi-asserted-by":"crossref","first-page":"176","DOI":"10.7861\/clinmedicine.11-2-176","article-title":"Non-alcoholic fatty liver disease: a massive problem","volume":"11","author":"Day","year":"2011","journal-title":"Clin. Med. (Lond.)"},{"key":"10.1074\/jbc.RA119.012361_bib2","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1177\/1756283X11430859","article-title":"Secondary causes of nonalcoholic fatty liver disease","volume":"5","author":"Kneeman","year":"2012","journal-title":"Therap. Adv. Gastroenterol"},{"key":"10.1074\/jbc.RA119.012361_bib3","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.bbacli.2014.09.001","article-title":"Clinical spectrum of non-alcoholic fatty liver disease in diabetic and non-diabetic patients","volume":"3","author":"Goh","year":"2015","journal-title":"BBA Clin"},{"key":"10.1074\/jbc.RA119.012361_bib4","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.2337\/diacare.26.11.2983","article-title":"Use of thiazolidinediones and risk of heart failure in people with type 2 diabetes: a retrospective cohort study","volume":"26","author":"Delea","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1074\/jbc.RA119.012361_bib5","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jama.298.2.194","article-title":"Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis","volume":"298","author":"Amori","year":"2007","journal-title":"JAMA"},{"key":"10.1074\/jbc.RA119.012361_bib6","first-page":"S2","article-title":"The changing landscape of type 2 diabetes: the role of incretin-based therapies in managed care outcomes","volume":"13","author":"Triplitt","year":"2007","journal-title":"J. Manag. Care Pharm"},{"key":"10.1074\/jbc.RA119.012361_bib7","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1517\/14740330802432003","article-title":"Exenatide and pancreatitis: an update","volume":"7","author":"Bain","year":"2008","journal-title":"Expert Opin. Drug Saf"},{"key":"10.1074\/jbc.RA119.012361_bib8","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4103\/1947-2714.128471","article-title":"Canagliflozin: a novel SGLT2 inhibitor for type 2 diabetes mellitus","volume":"6","author":"Kaushal","year":"2014","journal-title":"N. Am. J. Med. Sci"},{"key":"10.1074\/jbc.RA119.012361_bib9","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/ncpendmet0889","article-title":"Gastric banding to treat obesity: band-aid or breakthrough","volume":"4","author":"Polonsky","year":"2008","journal-title":"Nat. Clin. Pract. Endocrinol. Metab"},{"key":"10.1074\/jbc.RA119.012361_bib10","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1038\/ijo.2013.38","article-title":"Roux-en-Y gastric bypass normalizes the blunted postprandial bile acid excursion associated with obesity","volume":"37","author":"Ahmad","year":"2013","journal-title":"Int. J. Obes. (Lond.)"},{"key":"10.1074\/jbc.RA119.012361_bib11","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1038\/oby.2009.102","article-title":"Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism","volume":"17","author":"Patti","year":"2009","journal-title":"Obesity"},{"key":"10.1074\/jbc.RA119.012361_bib12","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.metabol.2009.05.006","article-title":"Serum bile acid along with plasma incretins and serum high-molecular weight adiponectin levels are increased after bariatric surgery","volume":"58","author":"Nakatani","year":"2009","journal-title":"Metabolism"},{"key":"10.1074\/jbc.RA119.012361_bib13","doi-asserted-by":"crossref","first-page":"E708","DOI":"10.1210\/jc.2012-3736","article-title":"Weight loss induced by Roux-en-Y gastric bypass but not laparoscopic adjustable gastric banding increases circulating bile acids","volume":"98","author":"Kohli","year":"2013","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"10.1074\/jbc.RA119.012361_bib14","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/oby.20548","article-title":"Vertical sleeve gastrectomy reduces hepatic steatosis while increasing serum bile acids in a weight-loss-independent manner","volume":"22","author":"Myronovych","year":"2014","journal-title":"Obesity"},{"key":"10.1074\/jbc.RA119.012361_bib15","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmet.2009.08.001","article-title":"TGR5-mediated bile acid sensing controls glucose homeostasis","volume":"10","author":"Thomas","year":"2009","journal-title":"Cell Metab"},{"key":"10.1074\/jbc.RA119.012361_bib16","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cmet.2005.09.001","article-title":"Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis","volume":"2","author":"Inagaki","year":"2005","journal-title":"Cell Metab"},{"key":"10.1074\/jbc.RA119.012361_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.taap.2017.06.023","article-title":"The effect of fibroblast growth factor 15 deficiency on the development of high fat diet-induced non-alcoholic steatohepatitis","volume":"330","author":"Schumacher","year":"2017","journal-title":"Toxicol. Appl. Pharmacol"},{"key":"10.1074\/jbc.RA119.012361_bib18","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cels.2017.12.006","article-title":"Integration of multi-omics data from mouse diversity panel highlights mitochondrial dysfunction in non-alcoholic fatty liver disease","volume":"6","author":"Chella Krishnan","year":"2018","journal-title":"Cell Syst"},{"key":"10.1074\/jbc.RA119.012361_bib19","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.bbamcr.2017.01.001","article-title":"Endoplasmic reticulum-mitochondria calcium signaling in hepatic metabolic diseases","volume":"1864","author":"Rieusset","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Cell Res"},{"key":"10.1074\/jbc.RA119.012361_bib20","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.cmet.2015.06.010","article-title":"Calcium homeostasis and organelle function in the pathogenesis of obesity and diabetes","volume":"22","author":"Arruda","year":"2015","journal-title":"Cell Metab"},{"key":"10.1074\/jbc.RA119.012361_bib21","doi-asserted-by":"crossref","first-page":"19320","DOI":"10.1073\/pnas.1012044107","article-title":"Sarco(endo)plasmic reticulum Ca2+-ATPase 2b is a major regulator of endoplasmic reticulum stress and glucose homeostasis in obesity","volume":"107","author":"Park","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA119.012361_bib22","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nature10988","article-title":"Inositol-1,4,5-trisphosphate receptor regulates hepatic gluconeogenesis in fasting and diabetes","volume":"485","author":"Wang","year":"2012","journal-title":"Nature"},{"key":"10.1074\/jbc.RA119.012361_bib23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/hep4.1012","article-title":"Hepatic inositol 1,4,5 trisphosphate receptor type 1 mediates fatty liver","volume":"1","author":"Feriod","year":"2017","journal-title":"Hepatol. Commun"},{"key":"10.1074\/jbc.RA119.012361_bib24","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.gene.2006.04.027","article-title":"Expression and tissue distribution of mouse Hax1","volume":"379","author":"Hippe","year":"2006","journal-title":"Gene"},{"key":"10.1074\/jbc.RA119.012361_bib25","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.bbagen.2009.06.004","article-title":"HAX-1: a multifunctional protein with emerging roles in human disease","volume":"1790","author":"Fadeel","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1074\/jbc.RA119.012361_bib26","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.yjmcc.2009.10.028","article-title":"HAX-1: a multifaceted antiapoptotic protein localizing in the mitochondria and the sarcoplasmic reticulum of striated muscle cells","volume":"48","author":"Yap","year":"2010","journal-title":"J. Mol. Cell. Cardiol"},{"key":"10.1074\/jbc.RA119.012361_bib27","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1517\/14728222.2011.561787","article-title":"HAX-1: a regulator of calcium signaling and apoptosis progression with multiple roles in human disease","volume":"15","author":"Simmen","year":"2011","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1074\/jbc.RA119.012361_bib28","doi-asserted-by":"crossref","first-page":"22461","DOI":"10.1074\/jbc.M109.086587","article-title":"Deregulation of mitochondrial membrane potential by mitochondrial insertion of granzyme B and direct HAX-1 cleavage","volume":"285","author":"Han","year":"2010","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.012361_bib29","doi-asserted-by":"crossref","first-page":"20776","DOI":"10.1073\/pnas.0906998106","article-title":"The anti-apoptotic protein HAX-1 is a regulator of cardiac function","volume":"106","author":"Zhao","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA119.012361_bib30","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.yjmcc.2017.11.014","article-title":"HAX-1 regulates SERCA2a oxidation and degradation","volume":"114","author":"Bidwell","year":"2018","journal-title":"J. Mol. Cell. Cardiol"},{"key":"10.1074\/jbc.RA119.012361_bib31","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1091\/mbc.e08-06-0587","article-title":"The anti-apoptotic protein HAX-1 interacts with SERCA2 and regulates its protein levels to promote cell survival","volume":"20","author":"Vafiadaki","year":"2009","journal-title":"Mol. Biol. Cell"},{"key":"10.1074\/jbc.RA119.012361_bib32","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1161\/CIRCRESAHA.112.279935","article-title":"Novel role of HAX-1 in ischemic injury protection: involvement of heat shock protein 90","volume":"112","author":"Lam","year":"2013","journal-title":"Circ. Res"},{"key":"10.1074\/jbc.RA119.012361_bib33","doi-asserted-by":"crossref","first-page":"32761","DOI":"10.1074\/jbc.M404337200","article-title":"Identificaiton of HAX-1 as a protein that binds bile salt export protein and regulates its abundance in the apical membrane of Mardin-Darby canine kidney cells","volume":"279","author":"Ortiz","year":"2004","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.012361_bib34","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1089\/humc.2013.082","article-title":"Biodistribution of AAV8 vectors expressing human low density lipoprotein receptor in a mouse model of homozygous familial hypercholesterolemia","volume":"24","author":"Chen","year":"2013","journal-title":"Hum. Gene Ther. Clin. Dev"},{"key":"10.1074\/jbc.RA119.012361_bib35","doi-asserted-by":"crossref","first-page":"10654","DOI":"10.1038\/s41598-017-10339-5","article-title":"The PDK1 inhibitor dichloroacetate controls cholesterol homeostasis through the ERK5\/MEF2 pathway","volume":"7","author":"Khan","year":"2017","journal-title":"Sci. Rep"},{"key":"10.1074\/jbc.RA119.012361_bib36","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.bbabio.2009.01.005","article-title":"Regulation of mitochondrial dehydrogenases by calcium ions","volume":"1787","author":"Denton","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1074\/jbc.RA119.012361_bib37","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1038\/nm.3735","article-title":"Chronic enrichment of hepatic endoplasmic reticulum-mitochondria contact leads to mitochondrial dysfunction in obesity","volume":"20","author":"Arruda","year":"2014","journal-title":"Nat. Med"},{"key":"10.1074\/jbc.RA119.012361_bib38","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.molmet.2014.05.004","article-title":"ER calcium release promotes mitochondrial dysfunction and hepatic cell lipotoxicity in response to palmitate overload","volume":"3","author":"Egnatchik","year":"2014","journal-title":"Mol. Metab"},{"key":"10.1074\/jbc.RA119.012361_bib39","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1002\/hep.24548","article-title":"Type 2 inositol 1,4,5-trisphosphate receptor modulates bile salt export pump activity in rat hepatocytes","volume":"54","author":"Kruglov","year":"2011","journal-title":"Hepatology"},{"key":"10.1074\/jbc.RA119.012361_bib40","doi-asserted-by":"crossref","first-page":"G221","DOI":"10.1152\/ajpgi.00322.2012","article-title":"Hepatic overexpression of abcb11 in mice promotes the conservation of bile acids within the enterohepatic circulation","volume":"304","author":"Henkel","year":"2013","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol"},{"key":"10.1074\/jbc.RA119.012361_bib41","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1074\/jbc.M307363200","article-title":"Hepatic overexpression of murine Abcb11 increases hepatobiliary lipid secretion and reduces hepatic steatosis","volume":"279","author":"Figge","year":"2004","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.012361_bib42","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/hep.24107","article-title":"Overexpression of cholesterol 7a hydrolase promotes hepatic bile acid synthesis and secretion and maintains cholesterol homeostasis","volume":"53","author":"Li","year":"2011","journal-title":"Hepatology"},{"key":"10.1074\/jbc.RA119.012361_bib43","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1172\/JCI21025","article-title":"Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c","volume":"113","author":"Watanabe","year":"2004","journal-title":"J. Clin. Invest"},{"key":"10.1074\/jbc.RA119.012361_bib44","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.bbalip.2007.02.012","article-title":"Steroidogenic acute regulatory protein (StAR), a novel mitochondrial cholesterol transporter","volume":"1771","author":"Miller","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1074\/jbc.RA119.012361_bib45","doi-asserted-by":"crossref","first-page":"48158","DOI":"10.1074\/jbc.M205244200","article-title":"Transport of cholesterol into mitochondria is rate-limiting for bile acid synthesis via the alternative pathway in primary rat hepatocytes","volume":"277","author":"Pandak","year":"2002","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.012361_bib46","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1210\/me.2002-0120","article-title":"Bile acids induce the expression of the human peroxisome proliferator-activated receptor a gene via activation of the farnesoid X receptor","volume":"17","author":"Pineda Torra","year":"2003","journal-title":"Mol. Endocrinol"},{"key":"10.1074\/jbc.RA119.012361_bib47","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.biocel.2009.12.009","article-title":"Lipolysis in adipocytes","volume":"42","author":"Ahmadian","year":"2010","journal-title":"Int. J. Biochem. Cell Biol"},{"key":"10.1074\/jbc.RA119.012361_bib48","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.cell.2010.06.007","article-title":"Essential regulation of cell bioenergetics by constitutive InsP3 receptor Ca2+ transfer to mitochondria","volume":"142","author":"C\u00e1rdenas","year":"2010","journal-title":"Cell"},{"key":"10.1074\/jbc.RA119.012361_bib49","doi-asserted-by":"crossref","first-page":"E1057","DOI":"10.1152\/ajpendo.00236.2014","article-title":"Inositol 1,4,5-trisphosphate receptor type II (InsP3R-II) is reduced in obese mice, but metabolic homeostasis is preserved in mice lacking InsP3R-II","volume":"307","author":"Feriod","year":"2014","journal-title":"Am. J. Physiol. Endocrinol. Metab"},{"key":"10.1074\/jbc.RA119.012361_bib50","doi-asserted-by":"crossref","first-page":"E46","DOI":"10.1152\/ajpendo.00536.2007","article-title":"Pyruvate dehydrogenase kinase-4 deficiency lowers blood glucose and improves glucose tolerance in diet-induced obese mice","volume":"295","author":"Jeoung","year":"2008","journal-title":"Am. J. Physiol. Endocrinol. Metab"},{"key":"10.1074\/jbc.RA119.012361_bib51","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.2337\/db16-0223","article-title":"Inhibition of pyruvate dehydrogenase kinase 2 protects against hepatic steatosis through modulation of tricarboxylic acid cycle anaplerosis and ketogenesis","volume":"65","author":"Go","year":"2016","journal-title":"Diabetes"},{"key":"10.1074\/jbc.RA119.012361_bib52","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.molmet.2018.03.014","article-title":"Targeting hepatic pyruvate dehydrogenase kinases restores insulin signaling and mitigates ChREBP-mediated lipogenesis in diet-induced obese mice","volume":"12","author":"Wu","year":"2018","journal-title":"Mol. Metab"},{"key":"10.1074\/jbc.RA119.012361_bib53","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.tem.2014.10.002","article-title":"Tissue-specific actions of the metabolic hormones FGF15\/19 and FGF21","volume":"26","author":"Owen","year":"2015","journal-title":"Trends Endocrinol. Metab"},{"key":"10.1074\/jbc.RA119.012361_bib54","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1365-2362.2010.02300.x","article-title":"Transgenic overexpression of Abcb11 enhances biliary bile salt outputs, but does not affect cholesterol cholelithogenesis in mice","volume":"40","author":"Wang","year":"2010","journal-title":"Eur. J. Clin. Invest"},{"key":"10.1074\/jbc.RA119.012361_bib55","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nature06604","article-title":"Hax1-mediated processing of HtrA2 by Parl allow survival of lymphocytes and neurons","volume":"452","author":"Chao","year":"2008","journal-title":"Nature"},{"key":"10.1074\/jbc.RA119.012361_bib56","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1172\/JCI31929","article-title":"Adipocyte LDL receptor-related protein-1 expression modulates postprandial lipid transport and glucose homeostasis in mice","volume":"117","author":"Hofmann","year":"2007","journal-title":"J. Clin. Invest"},{"key":"10.1074\/jbc.RA119.012361_bib57","doi-asserted-by":"crossref","first-page":"16610","DOI":"10.1074\/jbc.M116.717744","article-title":"LRP1 protein deficiency exacerbates palmitate-induced steatosis and toxicity in hepatocytes","volume":"291","author":"Hamlin","year":"2016","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.012361_bib58","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S1096-7192(03)00017-9","article-title":"Characterization of fatty acid oxidation in human muscle mitochondria and myoblasts","volume":"78","author":"Djouadi","year":"2003","journal-title":"Mol. Genet. Metab"},{"key":"10.1074\/jbc.RA119.012361_bib59","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/0076-6879(90)92092-R","article-title":"Preparation of basolateral (sinusoidal) and canalicular plasma membrane vesicles for the study of hepatic transport processes","volume":"192","author":"Meier","year":"1990","journal-title":"Methods Enzymol"},{"key":"10.1074\/jbc.RA119.012361_bib60","doi-asserted-by":"crossref","first-page":"935","DOI":"10.2337\/diabetes.55.04.06.db05-1286","article-title":"Group 1B phospholipase A2-mediated lysophospholipid absorption directly contributes to postprandial hyperglycemia","volume":"55","author":"Labont\u00e9","year":"2006","journal-title":"Diabetes"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925817487254?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925817487254?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.RA119.012361","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,31]],"date-time":"2021-12-31T15:24:59Z","timestamp":1640964299000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925817487254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":60,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0021925817487254"],"URL":"https:\/\/doi.org\/10.1074\/jbc.ra119.012361","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatic HAX-1 inactivation prevents metabolic diseases by enhancing mitochondrial activity and bile salt export","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/jbc.RA119.012361","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Alogaili et al.","name":"copyright","label":"Copyright"}]}}